iBio Appoints Molly Carr as Chief Medical Officer
iBio appointed endocrinologist Molly Carr, M.D., as chief medical officer effective July 31, 2026 and announced the appointment on August 4. She will lead global clinical strategy, medical affairs and regulatory work as the…
